Aditxt Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly12K
Quarterly Net Loss Quarterly-15.9M
Stockholders' Equity Quarterly4MTarget: >= 2500000
Watch Items
- Ignite Proteomics SPAC Merger ClosingTrigger: September 30, 2026Action: Monitor SEC registration statement effectiveness, Copley Acquisition Corp shareholder approval, and NYSE listing approval.
- Nasdaq Continued Listing ComplianceTrigger: Stockholders' equity falling below $2.5 million or market cap falling below Nasdaq thresholdsAction: Evaluate capital raising activities, including the H.C. Wainwright at-the-market (ATM) offering expansion.
- Going Concern Status and Cash RunwayTrigger: Cash reserves insufficient to fund 12 months of operationsAction: Track private placements of promissory notes and other dilutive financing mechanisms.
Research as of 20 Jun 2026